Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 28:2018:bcr2018225984.
doi: 10.1136/bcr-2018-225984.

Neuromyelitis optica with unilateral diaphragmatic paralysis

Affiliations
Case Reports

Neuromyelitis optica with unilateral diaphragmatic paralysis

Sami Bennji et al. BMJ Case Rep. .

Abstract

In this case report, we describe the course of a female patient who is known to have neuromyelitis optica (NMO) and developed left hemiparesis and unilateral diaphragmatic paralysis. She was initially treated with intravenous methylprednisolone 1 g daily for 5 days without improvement. Subsequently, she received five sessions of a plasmapheresis. Her hemiparesis had improved after few days. however, the phrenic nerve palsy remained.

Keywords: neurology; respiratory system.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Chest radiograph (posteroanterior view) showing the elevated left diaphragmatic dome.
Figure 2
Figure 2
(A) T2-weighted MRI image showing hyperintense lesion extending from the medulla to T6 was seen (arrows). (B) T1-weighted MRI image postcontrast studies showing multiple enhancing lesions in the medulla, upper and middle portions of the cervical cord, along with a lesion in the thoracic cord (arrows).
Figure 3
Figure 3
T2-weighted MRI transverse image at the level of C3 showing hyperdense lesions (arrow).

References

    1. Lucchinetti CF, Mandler RN, McGavern D, et al. . A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002;125:1450–61. 10.1093/brain/awf151 - DOI - PMC - PubMed
    1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. . A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106–12. 10.1016/S0140-6736(04)17551-X - DOI - PubMed
    1. Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol 2010;12:244–55. 10.1007/s11940-010-0071-z - DOI - PubMed
    1. Mesa A, Somarelli JA, Wu W, et al. . Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease. Lupus 2013;22:1371–81. 10.1177/0961203313508444 - DOI - PMC - PubMed
    1. Wingerchuk DM, Banwell B, Bennett JL, et al. . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–89. 10.1212/WNL.0000000000001729 - DOI - PMC - PubMed

Publication types